Table Filtering
Other Information
Release Statistics Download
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources January 28, 2025
Displaying entries 13351 - 13375 of 14279 in total
Disease ID Disease Name Alliance of Genome Resources ID Species Gene ID Gene Symbol FlyGlycoDB Evidence ▲ References
DOID:13252 mesenteric vascular occlusion RGD:2857 Rattus norvegicus (Norway rat) 25464 Icam1 mutant phenotype evidence used in manual assertion
  • PMID:7858885
DOID:10652 Alzheimer's disease HGNC:6893 Homo sapiens (human) 4137 MAPT mutant phenotype evidence used in manual assertion
  • PMID:11520987
  • PMID:19252918
DOID:0080630 B-lymphoblastic leukemia/lymphoma HGNC:11928 Homo sapiens (human) 8741 TNFSF13 mutant phenotype evidence used in manual assertion
  • PMID:15488762
DOID:2799 bronchiolitis obliterans RGD:3645 Rattus norvegicus (Norway rat) 24770 Ccl2 mutant phenotype evidence used in manual assertion
  • PMID:14611812
DOID:9744 type 1 diabetes mellitus HGNC:1700 Homo sapiens (human) 941 CD80 mutant phenotype evidence used in manual assertion
  • PMID:19658094
DOID:0080199 colorectal carcinoma HGNC:3227 Homo sapiens (human) 1948 EFNB2 mutant phenotype evidence used in manual assertion
  • PMID:26494468
DOID:0060319 cardiac arrest RGD:3786 Rattus norvegicus (Norway rat) 25559 Abcc8 mutant phenotype evidence used in manual assertion
  • PMID:26010685
DOID:0080855 Parkinsonism HGNC:16369 Homo sapiens (human) 11315 PARK7 mutant phenotype evidence used in manual assertion
  • PMID:16860563
DOID:4362 cervical cancer HGNC:10771 Homo sapiens (human) 10262 SF3B4 mutant phenotype evidence used in manual assertion
  • PMID:35853859
DOID:14330 Parkinson's disease HGNC:11138 Homo sapiens (human) 6622 SNCA mutant phenotype evidence used in manual assertion
  • PMID:10678833
  • PMID:18178617
DOID:1936 atherosclerosis RGD:2998 Rattus norvegicus (Norway rat) 300438 Ldlr mutant phenotype evidence used in manual assertion
  • PMID:22293196
DOID:0080187 chronic neutrophilic leukemia HGNC:2439 Homo sapiens (human) 1441 CSF3R mutant phenotype evidence used in manual assertion
  • PMID:24081659
DOID:14504 Niemann-Pick disease WB:WBGene00003561 Caenorhabditis elegans 180719 ncr-1 mutant phenotype evidence used in manual assertion
  • PMID:10801441
  • PMID:15509773
DOID:0110861 autosomal recessive polycystic kidney disease RGD:2493 Rattus norvegicus (Norway rat) 24310 Ace mutant phenotype evidence used in manual assertion
  • PMID:20229187
DOID:0080000 muscular disease HGNC:6677 Homo sapiens (human) 4023 LPL mutant phenotype evidence used in manual assertion
  • PMID:7635990
DOID:0050967 spinocerebellar ataxia type 17 HGNC:11588 Homo sapiens (human) 6908 TBP mutant phenotype evidence used in manual assertion
  • PMID:23699518
DOID:14504 Niemann-Pick disease WB:WBGene00003562 Caenorhabditis elegans 176165 ncr-2 mutant phenotype evidence used in manual assertion
  • PMID:10801441
  • PMID:15509773
DOID:10303 sialadenitis RGD:2306 Rattus norvegicus (Norway rat) 24932 Cd4 mutant phenotype evidence used in manual assertion
  • PMID:1828009
DOID:4780 anti-basement membrane glomerulonephritis HGNC:2505 Homo sapiens (human) 1493 CTLA4 mutant phenotype evidence used in manual assertion
  • PMID:10712436
DOID:9744 type 1 diabetes mellitus RGD:708418 Rattus norvegicus (Norway rat) 84349 Cd40lg mutant phenotype evidence used in manual assertion
  • PMID:12419284
  • PMID:16611325
DOID:10873 Kuhnt-Junius degeneration HGNC:3763 Homo sapiens (human) 2321 FLT1 mutant phenotype evidence used in manual assertion
  • PMID:20609706
DOID:12930 dilated cardiomyopathy RGD:68380 Rattus norvegicus (Norway rat) 59106 Ltbp2 mutant phenotype evidence used in manual assertion
  • PMID:31512380
DOID:224 transient cerebral ischemia RGD:2737 Rattus norvegicus (Norway rat) 24409 Grin2a mutant phenotype evidence used in manual assertion
  • PMID:30885791
DOID:326 ischemia RGD:2254 Rattus norvegicus (Norway rat) 24241 Calca mutant phenotype evidence used in manual assertion
  • PMID:21181115
DOID:11984 hypertrophic cardiomyopathy RGD:2990 Rattus norvegicus (Norway rat) 24944 Lamp2 mutant phenotype evidence used in manual assertion
  • PMID:29720683

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.4.0

Last updated: December 8, 2025